Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISAL 2019 | Key population-based registry studies in hematological oncology

Magnus Björkholm • 15 Mar 2019
ISAL 2019
Chronic Lymphocytic Leukemia General Leukemia Multiple Myeloma Myeloproliferative Neoplasms

Magnus Björkholm, MD, PhD, of the Karolinska Institute, Stockholm, Sweden, speaks at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany. He discusses key examples of where population-based registry studies have answered questions in the field of hematological oncology, including chronic lymphocytic leukemia, multiple myeloma and myeloproliferative neoplasms.

More from Magnus Björkholm

5:03
Progress in ALL & trends in the survival of young adult patients in Sweden and the USA
Magnus Björkholm • 15 Mar 2019

Related Videos

2:00
HHV-6 reactivation after haploidentical transplantation with PTCy & ATG: incidence and risk factors
Rémy Duléry • 15 Apr 2024
5:23
Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD
Mohamad Mohty • 17 Apr 2024
2:25
Optimizing haplo-SCT for the treatment of AML
Arnon Nagler • 16 Apr 2024
4:07
Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD
Florent Malard • 11 Apr 2024
The content of VJHemOnc is intended for healthcare professionals